NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.49 Million USD | 61.74% |
| 2022 | -3.89 Million USD | 82.5% |
| 2021 | -22.26 Million USD | -367.29% |
| 2020 | -4.76 Million USD | -115.65% |
| 2019 | -2.2 Million USD | 54.92% |
| 2018 | -4.9 Million USD | -21.22% |
| 2017 | -4.04 Million USD | -2.39% |
| 2016 | -3.94 Million USD | 68.31% |
| 2015 | -12.46 Million USD | -35.14% |
| 2014 | -9.22 Million USD | -0.29% |
| 2013 | -9.19 Million USD | -5.92% |
| 2012 | -8.68 Million USD | 15.32% |
| 2011 | -10.25 Million USD | 39.44% |
| 2010 | -16.92 Million USD | 25.99% |
| 2009 | -22.87 Million USD | -87.18% |
| 2008 | -12.22 Million USD | -72.95% |
| 2007 | -7.06 Million USD | 10.67% |
| 2006 | -7.9 Million USD | 3.19% |
| 2005 | -8.17 Million USD | -321.95% |
| 2004 | -1.93 Million USD | -306.05% |
| 2003 | 939.7 Thousand USD | 134.89% |
| 2002 | -2.69 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.43 Million USD | -36.15% |
| 2024 Q3 | -778.89 Thousand USD | 45.55% |
| 2024 Q1 | -1.05 Million USD | 29.54% |
| 2023 Q1 | -2.19 Million USD | 43.65% |
| 2023 FY | -1.49 Million USD | 61.74% |
| 2023 Q4 | -1.49 Million USD | -11.47% |
| 2023 Q3 | -1.33 Million USD | 21.81% |
| 2023 Q2 | -1.71 Million USD | 22.1% |
| 2022 FY | -3.89 Million USD | 82.5% |
| 2022 Q1 | -23.33 Million USD | -4.82% |
| 2022 Q2 | -5.59 Million USD | 76.03% |
| 2022 Q3 | -1.38 Million USD | 75.16% |
| 2022 Q4 | -3.89 Million USD | -180.4% |
| 2021 FY | -22.26 Million USD | -367.29% |
| 2021 Q4 | -22.26 Million USD | 1.21% |
| 2021 Q1 | -4.2 Million USD | 11.7% |
| 2021 Q2 | -7.55 Million USD | -79.59% |
| 2021 Q3 | -22.53 Million USD | -198.31% |
| 2020 Q2 | -4.14 Million USD | -192.8% |
| 2020 Q1 | -1.41 Million USD | 35.96% |
| 2020 Q3 | -4.34 Million USD | -4.93% |
| 2020 Q4 | -4.76 Million USD | -9.6% |
| 2020 FY | -4.76 Million USD | -115.65% |
| 2019 Q4 | -2.2 Million USD | -39.63% |
| 2019 Q2 | -3.84 Million USD | 35.86% |
| 2019 Q1 | -5.98 Million USD | -9.31% |
| 2019 FY | -2.2 Million USD | 54.92% |
| 2019 Q3 | -1.58 Million USD | 58.8% |
| 2018 FY | -4.9 Million USD | -21.22% |
| 2018 Q2 | -7.1 Million USD | -16.58% |
| 2018 Q1 | -6.09 Million USD | -50.8% |
| 2018 Q4 | -5.47 Million USD | 27.24% |
| 2018 Q3 | -7.53 Million USD | -5.93% |
| 2017 FY | -4.04 Million USD | -2.39% |
| 2017 Q4 | -4.04 Million USD | -1.88% |
| 2017 Q3 | -3.96 Million USD | -9.89% |
| 2017 Q2 | -3.61 Million USD | 47.63% |
| 2017 Q1 | -6.89 Million USD | -74.65% |
| 2016 Q4 | -3.94 Million USD | 47.82% |
| 2016 Q1 | -8.73 Million USD | 29.87% |
| 2016 Q2 | -11.33 Million USD | -29.65% |
| 2016 FY | -3.94 Million USD | 68.31% |
| 2016 Q3 | -7.56 Million USD | 33.21% |
| 2015 Q2 | -12.63 Million USD | -97.39% |
| 2015 FY | -12.46 Million USD | -35.14% |
| 2015 Q4 | -12.46 Million USD | -36.7% |
| 2015 Q3 | -9.11 Million USD | 27.87% |
| 2015 Q1 | -6.4 Million USD | 30.57% |
| 2014 Q2 | -13.69 Million USD | -80.57% |
| 2014 Q4 | -9.22 Million USD | 21.09% |
| 2014 FY | -9.22 Million USD | -0.29% |
| 2014 Q1 | -7.58 Million USD | 17.53% |
| 2014 Q3 | -11.68 Million USD | 14.65% |
| 2013 Q2 | -9.57 Million USD | -39.36% |
| 2013 Q3 | -7.83 Million USD | 18.2% |
| 2013 Q4 | -9.19 Million USD | -17.35% |
| 2013 FY | -9.19 Million USD | -5.92% |
| 2013 Q1 | -6.87 Million USD | 20.83% |
| 2012 Q2 | -13.29 Million USD | 12.4% |
| 2012 Q3 | -10.9 Million USD | 18.01% |
| 2012 Q4 | -8.68 Million USD | 20.37% |
| 2012 Q1 | -15.17 Million USD | -48.06% |
| 2012 FY | -8.68 Million USD | 15.32% |
| 2011 FY | -10.25 Million USD | 39.44% |
| 2011 Q1 | -15.05 Million USD | 11.1% |
| 2011 Q4 | -10.25 Million USD | 12.16% |
| 2011 Q3 | -11.67 Million USD | 14.03% |
| 2011 Q2 | -13.57 Million USD | 9.8% |
| 2010 FY | -16.92 Million USD | 25.99% |
| 2010 Q3 | -18.88 Million USD | 0.78% |
| 2010 Q4 | -16.92 Million USD | 10.34% |
| 2010 Q2 | -19.03 Million USD | 8.22% |
| 2010 Q1 | -20.73 Million USD | 9.35% |
| 2009 Q1 | -5.83 Million USD | 52.22% |
| 2009 FY | -22.87 Million USD | -87.18% |
| 2009 Q4 | -22.87 Million USD | -4.13% |
| 2009 Q3 | -21.96 Million USD | -307.57% |
| 2009 Q2 | -5.38 Million USD | 7.69% |
| 2008 Q2 | -13.48 Million USD | -24.25% |
| 2008 Q1 | -10.85 Million USD | -53.64% |
| 2008 Q4 | -12.22 Million USD | 43.35% |
| 2008 Q3 | -21.57 Million USD | -59.91% |
| 2008 FY | -12.22 Million USD | -72.95% |
| 2007 Q3 | -6.66 Million USD | -40.64% |
| 2007 Q1 | -6.81 Million USD | 13.83% |
| 2007 FY | -7.06 Million USD | 10.67% |
| 2007 Q4 | -7.06 Million USD | -6.01% |
| 2007 Q2 | -4.73 Million USD | 30.47% |
| 2006 Q1 | -5.39 Million USD | 33.96% |
| 2006 Q2 | -5.16 Million USD | 4.33% |
| 2006 Q3 | -6.56 Million USD | -27.22% |
| 2006 Q4 | -7.9 Million USD | -20.45% |
| 2006 FY | -7.9 Million USD | 3.19% |
| 2005 Q1 | -2.43 Million USD | -25.9% |
| 2005 FY | -8.17 Million USD | -321.95% |
| 2005 Q4 | -8.17 Million USD | -147.31% |
| 2005 Q3 | -3.3 Million USD | -19.35% |
| 2005 Q2 | -2.76 Million USD | -13.55% |
| 2004 Q2 | -7.81 Million USD | 6.03% |
| 2004 Q3 | -30.64 Million USD | -292.06% |
| 2004 FY | -1.93 Million USD | -306.05% |
| 2004 Q4 | -1.93 Million USD | 93.68% |
| 2004 Q1 | -8.31 Million USD | -985.07% |
| 2003 FY | 939.7 Thousand USD | 134.89% |
| 2003 Q4 | 939.7 Thousand USD | 0.0% |
| 2002 FY | -2.69 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 105.506% |
| BrainsWay Ltd. | -10.32 Million USD | 85.552% |
| Cerus Corporation | 84.35 Million USD | 101.768% |
| Envoy Medical, Inc. | -3.81 Million USD | 60.905% |
| electroCore, Inc. | -9.95 Million USD | 85.022% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 70.906% |
| IceCure Medical Ltd | -9.93 Million USD | 84.99% |
| Inogen, Inc. | -103.56 Million USD | 98.56% |
| OrthoPediatrics Corp. | -9.26 Million USD | 83.91% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 59.048% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 88.615% |
| MaxCyte, Inc. | -27.76 Million USD | 94.629% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 70.98% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -158.971% |
| Orthofix Medical Inc. | 96.44 Million USD | 101.546% |
| PAVmed Inc | 29.08 Million USD | 105.126% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 91.197% |
| RxSight, Inc. | -6.68 Million USD | 77.679% |
| Sight Sciences, Inc. | -102.71 Million USD | 98.548% |
| SI-BONE, Inc. | 5.72 Million USD | 126.063% |
| TELA Bio, Inc. | -3.94 Million USD | 62.242% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 102.601% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 523.599% |
| Acutus Medical, Inc. | 12.27 Million USD | 112.143% |
| Talis Biomedical Corporation | -57.06 Million USD | 97.387% |
| Spectral AI, Inc. | -3.5 Million USD | 57.41% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 96.895% |
| CVRx, Inc. | -59.95 Million USD | 97.513% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 175.149% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 216.705% |
| Bioventus Inc. | 372.51 Million USD | 100.4% |
| Venus Concept Inc. | 74.3 Million USD | 102.007% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 85.356% |
| LivaNova PLC | 62.53 Million USD | 102.384% |
| 908 Devices Inc. | -115.09 Million USD | 98.704% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 100.465% |
| Nemaura Medical Inc. | 9.92 Million USD | 115.023% |
| NeuroPace, Inc. | 54.33 Million USD | 102.744% |
| LENSAR, Inc. | -18.31 Million USD | 91.857% |
| Apyx Medical Corporation | -5.15 Million USD | 71.053% |
| Cutera, Inc. | 288.3 Million USD | 100.517% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 119.841% |
| BioSig Technologies, Inc. | 262 Thousand USD | 669.111% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 96.598% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 83.791% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.106% |
| Axonics, Inc. | -77.19 Million USD | 98.068% |
| Outset Medical, Inc. | 67.67 Million USD | 102.203% |
| IRIDEX Corporation | -4.28 Million USD | 65.227% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 99.162% |
| IRadimed Corporation | -47.71 Million USD | 96.875% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 50.725% |
| INVO Bioscience, Inc. | 8.45 Million USD | 117.643% |
| Telesis Bio, Inc. | 32.63 Million USD | 104.569% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 40.408% |
| Varex Imaging Corporation | 316.9 Million USD | 100.471% |
| Quipt Home Medical Corp. | 81.73 Million USD | 101.824% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 46.403% |
| Pulmonx Corporation | -42.36 Million USD | 96.48% |
| Dynatronics Corporation | 6.2 Million USD | 124.034% |
| Modular Medical, Inc. | -8.04 Million USD | 81.459% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 65.3% |
| Semler Scientific, Inc. | -57.13 Million USD | 97.39% |
| InMode Ltd. | -135.39 Million USD | 98.899% |
| Bruker Corporation | 891.3 Million USD | 100.167% |
| Cytosorbents Corporation | 4.18 Million USD | 135.654% |
| DexCom, Inc. | 2.02 Billion USD | 100.074% |
| Align Technology, Inc. | -840.47 Million USD | 99.823% |
| Viveve Medical, Inc. | -13.81 Million USD | 89.205% |
| ZimVie Inc. | 450.41 Million USD | 100.331% |
| Movano Inc. | -5.86 Million USD | 74.581% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 98.891% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -158.971% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 175.149% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.418% |
| Profound Medical Corp. | -18.17 Million USD | 91.798% |
| Insulet Corporation | 798.1 Million USD | 100.187% |
| enVVeno Medical Corporation | -2.21 Million USD | 32.774% |
| Surmodics, Inc. | -12.01 Million USD | 87.589% |
| iCAD, Inc. | -21.2 Million USD | 92.97% |
| Nuwellis, Inc. | -2.81 Million USD | 47.106% |
| Biotricity, Inc. | 23.09 Million USD | 106.457% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 101.592% |
| Aethlon Medical, Inc. | -4.5 Million USD | 66.877% |
| InspireMD, Inc. | -8.04 Million USD | 81.466% |
| PAVmed Inc. | 29.08 Million USD | 105.126% |
| BIOLASE, Inc. | 11.34 Million USD | 113.144% |
| Beyond Air, Inc. | 6.22 Million USD | 123.938% |
| FONAR Corporation | -14.66 Million USD | 89.833% |
| AxoGen, Inc. | 32.26 Million USD | 104.621% |
| Vivani Medical, Inc. | 42 Thousand USD | 3650.167% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 86.01% |
| Inari Medical, Inc. | -7.16 Million USD | 79.178% |
| UFP Technologies, Inc. | 40.77 Million USD | 103.657% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 148.591% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 68.749% |
| Tenon Medical, Inc. | -1.25 Million USD | -18.81% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 80.396% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 87.498% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.067% |
| Sintx Technologies, Inc. | 905 Thousand USD | 264.759% |
| NanoVibronix, Inc. | -3.27 Million USD | 54.513% |
| Quanterix Corporation | -132.95 Million USD | 98.879% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 46.403% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 93.333% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.198% |
| TransMedics Group, Inc. | 121.13 Million USD | 101.231% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 94.305% |
| Hyperfine, Inc. | -75.61 Million USD | 98.028% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 100.98% |
| Biomerica, Inc. | -3.38 Million USD | 55.951% |
| Bone Biologics Corporation | -3.02 Million USD | 50.734% |
| AVITA Medical, Inc. | -26.23 Million USD | 94.316% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 18.894% |
| Silk Road Medical, Inc | 64.42 Million USD | 102.314% |